A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Epstein-Barr Virus, ISH without Interpretation
Test Code16689X
CPT Codes
88365
Preferred Specimen
Formalin-fixed paraffin-embedded tissue block
Transport Temperature
Room temperature
Specimen Stability
Room temperature: Indefinite
Refrigerated: Indefinite
Frozen: Do Not Freeze
Refrigerated: Indefinite
Frozen: Do Not Freeze
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Sample in fixative
Methodology
In-Situ Hybridization
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Sets up Mon through Sat AM
Clinical Significance
The presence of Epstein-Barr virus (EBV) in tumors or reactive tissues can be detected by expression of the EBV-associated small RNAs (EBERs) using in situ hybridization. EBER expression is seen in all EBV-associated malignancies including classical Hodgkin lymphoma (most commonly mixed cellularity type), nasopharyngeal carcinoma, post-transplant B-cell lymphoproliferative disorders, a subset of diffuse large B-cell lymphomas, extranodal NK/T-cell lymphoma, nasal type, and some childhood T-cell lymphoproliferative disorders.